Ozempic was first approved in 2017 by the US Food and Drug Administration (FDA) as an injectable drug to help "lower blood sugar levels in adults with type 2 diabetes mellitus, in addition to diet and exercise." Wegovy was approved the same year to help adults and children aged 12 years and older, who were overweight or living with obesity
Barriers affecting physicians and health care workers could be addressed through programs such as skill enhancement and conferences
Yes, several dietary strategies and supplements have been shown to boost GLP-1 production, including high-protein foods, olive oil, fermentable fiber, allulose, berberine, EGCG, and curcumin
The original ADEL was launched in January 2018, however the new ADEL supports the new WADA International Standard for Education, which took effect on 1 January 2021 and is seen as a significant step forward in anti-doping education policy
Unlike prescription drugs, the FDA does not "approve" dietary supplements before they reach the market
